Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

Europe - FRA:AIL - FR0000120073 - Common Stock

172.78 EUR
-1.26 (-0.72%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

AIL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. While AIL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. While showing a medium growth rate, AIL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year AIL was profitable.
AIL had a positive operating cash flow in the past year.
AIL had positive earnings in each of the past 5 years.
AIL had a positive operating cash flow in each of the past 5 years.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

The Return On Assets of AIL (6.70%) is better than 76.81% of its industry peers.
The Return On Equity of AIL (13.49%) is better than 75.36% of its industry peers.
The Return On Invested Capital of AIL (9.87%) is better than 84.06% of its industry peers.
AIL had an Average Return On Invested Capital over the past 3 years of 9.47%. This is above the industry average of 7.19%.
The last Return On Invested Capital (9.87%) for AIL is above the 3 year average (9.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROIC 9.87%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

AIL's Profit Margin of 12.22% is amongst the best of the industry. AIL outperforms 88.41% of its industry peers.
AIL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 19.93%, AIL belongs to the top of the industry, outperforming 94.20% of the companies in the same industry.
In the last couple of years the Operating Margin of AIL has grown nicely.
The Gross Margin of AIL (63.01%) is better than 92.75% of its industry peers.
In the last couple of years the Gross Margin of AIL has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AIL is creating some value.
Compared to 1 year ago, AIL has about the same amount of shares outstanding.
Compared to 5 years ago, AIL has more shares outstanding
AIL has a better debt/assets ratio than last year.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.86. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
AIL has a better Altman-Z score (3.86) than 79.71% of its industry peers.
The Debt to FCF ratio of AIL is 4.60, which is a neutral value as it means it would take AIL, 4.60 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AIL (4.60) is better than 79.71% of its industry peers.
AIL has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
AIL has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Altman-Z 3.86
ROIC/WACC1.34
WACC7.36%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

AIL has a Current Ratio of 0.84. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.84, AIL is not doing good in the industry: 88.41% of the companies in the same industry are doing better.
A Quick Ratio of 0.61 indicates that AIL may have some problems paying its short term obligations.
With a Quick ratio value of 0.61, AIL is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.61
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.10% over the past year.
Measured over the past years, AIL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.55% on average per year.
Looking at the last year, AIL shows a decrease in Revenue. The Revenue has decreased by -1.99% in the last year.
Measured over the past years, AIL shows a small growth in Revenue. The Revenue has been growing by 4.30% on average per year.
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%

3.2 Future

Based on estimates for the next years, AIL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.00% on average per year.
Based on estimates for the next years, AIL will show a small growth in Revenue. The Revenue will grow by 4.18% on average per year.
EPS Next Y5.18%
EPS Next 2Y8.76%
EPS Next 3Y9.11%
EPS Next 5Y10%
Revenue Next Year0.67%
Revenue Next 2Y2.65%
Revenue Next 3Y3.56%
Revenue Next 5Y4.18%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.56, the valuation of AIL can be described as expensive.
AIL's Price/Earnings ratio is in line with the industry average.
AIL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 22.72 indicates a rather expensive valuation of AIL.
The rest of the industry has a similar Price/Forward Earnings ratio as AIL.
When comparing the Price/Forward Earnings ratio of AIL to the average of the S&P500 Index (22.94), we can say AIL is valued inline with the index average.
Industry RankSector Rank
PE 27.56
Fwd PE 22.72
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AIL's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, AIL is valued a bit cheaper than the industry average as 60.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 36.35
EV/EBITDA 13.8
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AIL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of AIL may justify a higher PE ratio.
PEG (NY)5.32
PEG (5Y)2.39
EPS Next 2Y8.76%
EPS Next 3Y9.11%

4

5. Dividend

5.1 Amount

AIL has a Yearly Dividend Yield of 1.92%.
Compared to an average industry Dividend Yield of 3.22, AIL has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, AIL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.86%.
Dividend Growth(5Y)5.86%
Div Incr Years6
Div Non Decr Years6
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AIL pays out 59.10% of its income as dividend. This is a bit on the high side, but may be sustainable.
AIL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP59.1%
EPS Next 2Y8.76%
EPS Next 3Y9.11%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (10/17/2025, 7:00:00 PM)

172.78

-1.26 (-0.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-21 2025-10-21
Inst Owners28.16%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap99.95B
Analysts80
Price Target202.17 (17.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend2.98
Dividend Growth(5Y)5.86%
DP59.1%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.89%
PT rev (3m)1.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.6%
EPS NY rev (3m)-4.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-2.91%
Valuation
Industry RankSector Rank
PE 27.56
Fwd PE 22.72
P/S 3.69
P/FCF 36.35
P/OCF 15.49
P/B 4.08
P/tB 10.93
EV/EBITDA 13.8
EPS(TTM)6.27
EY3.63%
EPS(NY)7.61
Fwd EY4.4%
FCF(TTM)4.75
FCFY2.75%
OCF(TTM)11.16
OCFY6.46%
SpS46.77
BVpS42.38
TBVpS15.81
PEG (NY)5.32
PEG (5Y)2.39
Profitability
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROCE 13.55%
ROIC 9.87%
ROICexc 10.27%
ROICexgc 16.67%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.16%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexcg growth 3Y3.94%
ROICexcg growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Debt/EBITDA 1.45
Cap/Depr 144.44%
Cap/Sales 13.69%
Interest Coverage 20.74
Cash Conversion 81.12%
Profit Quality 83.16%
Current Ratio 0.84
Quick Ratio 0.61
Altman-Z 3.86
F-Score7
WACC7.36%
ROIC/WACC1.34
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.93%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
EPS Next Y5.18%
EPS Next 2Y8.76%
EPS Next 3Y9.11%
EPS Next 5Y10%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%
Revenue Next Year0.67%
Revenue Next 2Y2.65%
Revenue Next 3Y3.56%
Revenue Next 5Y4.18%
EBIT growth 1Y6.38%
EBIT growth 3Y9.02%
EBIT growth 5Y7.28%
EBIT Next Year55.91%
EBIT Next 3Y21.96%
EBIT Next 5Y16.07%
FCF growth 1Y-11.78%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y-1.15%
OCF growth 3Y4.31%
OCF growth 5Y6.05%